Deep Dive: Huntington’s at a Crossroads
Recent breakthroughs and three decades of progress in treating Huntington’s disease
Recent breakthroughs and three decades of progress in treating Huntington’s disease
RWJBarnabas Health has signed a definitive agreement that would absorb Englewood Health — which operates one of the last independent hospitals in the state — into its larger system.
New Jersey healthcare giant poised to acquire another hospital Read More »
Roughly 1.5 million to 2 million questions are sent to the chatbot about health insurance each week, suggesting consumers are increasingly using AI to navigate the healthcare system, according to the report.
40M users turn to ChatGPT daily for health questions: OpenAI Read More »
The implantable lens maker said it would remain a stand-alone company after its shareholders turned down Alcon’s $1.6 billion offer.
STAAR shareholders reject Alcon’s revised buyout offer Read More »
Under the agreement, the engineering partner will be responsible for a significant portion of the software development for the Vicarious robotic system.
Vicarious inks software partnership as it streamlines operations Read More »
The US dramatically altered its recommendations for a series of vaccines, which drive billion-dollar earnings for giants like Merck and Pfizer.
Vaccine Investors Keep Their Heads Down as Trump Cuts Shot Schedule Read More »
Eli Lilly kicked off a pivotal 2026 campaign with a multi-year collaboration with current partner Nimbus Therapeutics worth a potential $1.3 billion for a preclinical obesity therapeutic. The deal follows a 2022 partnership struck by the companies to target the AMPK protein in cardiometabolic diseases.
Lilly Doubles Down with Nimbus, Paying $55M For Preclinical Obesity Drug Read More »
Arrowhead heralded the results as proof of concept that inhibiting the Activin E pathway can improve body composition and enhance weight loss as compared to tirzepatide alone, particularly in patients with type 2 diabetes.
Arrowhead Enters Obesity Chat by Doubling Tirzepatide’s Weight Loss in Combo Study Read More »
The agreement, which BMO Capital Markets called a “mild positive” for Structure, appears to address Roche’s concerns about the composition of investigational weight loss drug CT-996.
Roche Clears Obesity Pill Legal Concerns With Structure Patent Agreement Read More »
In a drastic decision made outside of its typical review process, the agency declared it would recommend 11 childhood shots going forward, down from 17.
CDC, following Trump’s orders, weakens US stance on childhood vaccinations Read More »